The common mucosal immune system and current strategies for induction of immune responses in external secretions View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1987-07

AUTHORS

Jiri Mestecky

ABSTRACT

The selective induction of antibodies in external secretions is desirable for the prevention of various systemic as well as predominantly mucosa-restricted infections. An enormous surface area of mucosal membranes is protected primarily by antibodies that belong, in many species, to the IgA isotype. Such antibodies are produced locally by large numbers of IgA-containing plasma cells distributed in subepithelial spaces of mucosal membranes and in the stroma of secretory glands. In humans and in some animal species, plasma-derived IgA antibodies do not enter external secretions in significant quantities and systemically administered preformed IgA antibodies would be of little use for passive immunization. Systemic administration of microbial antigens may boost an effective S-IgA immune response only in a situation whereby an immunized individual had previously encountered the same antigen by the mucosal route. Local injection of antigen in the vicinity of secretory glands is usually accompanied by an undesirable concomitant systemic response and frequently requires the addition of adjuvants that are unacceptable for administration in humans. Immunization routes that involve ingestion or possibly inhalation of antigens lead to the induction of not only local but also generalized immune responses manifested by the parallel appearance of S-Iga antibodies to ingested or inhaled antigens in secretions of glands distant from the site of immunization. Based on extensive studies in animal models as well as in humans, convincing evidence is available that antigen-sensitized and IgA-committed precursors of plasma cells from GALT are disseminated to the gut, other mucosa-associated tissues, and exocrine glands. However, due to the limited absorption of desired antigens from the gut lumen of orally immunized individuals, repeated large doses of antigens are required for an effective S-IgA response. Novel antigen delivery systems for the stimulation of such responses are currently being examined in several laboratories. Live attenuated or genetically manipulated bacteria expressing other microbial antigens have also been used for selective colonization of gut-associated lymphoid tissues. Unique antigen packaging and the use of adjuvants suitable for oral administration hold promise for an efficient antigen delivery to critical tissues in the intestine and deserve extensive exploration. The oral immunization route appears to have many advantages over systemic immunization.(ABSTRACT TRUNCATED AT 400 WORDS) More... »

PAGES

265-276

Journal

TITLE

Journal of Clinical Immunology

ISSUE

4

VOLUME

7

Related Patents

  • Vaccine Compositions And Method For Induction Of Mucosal Immune Response Via Systemic Vaccination
  • Vaccine
  • Nanoemulsion Therapeutic Compositions And Methods Of Using The Same
  • Bactericides And Vaccines
  • Nanoemulsion Therapeutic Compositions And Methods Of Using The Same
  • Oral Vaccine Fast-Dissolving Dosage Form Using Starch
  • Pneumococcus Polysaccharide-Related Vaccines
  • Method For Augmenting Immunological Responses
  • Antigens And Lymphoid Organ Modifiers Using Steroids
  • To Provide Protection Against Pneumococcal Colonization And Systemic Infection, Intranasally Administering A Composition Consisting Essentially Of Pneumococcal Surface Protein A Or A Fragment Containing A Protection-Eliciting Epitope
  • Mixture Of Antigen And Dehydroepiandrosterone
  • Vault Compositions For Immunization
  • Oral Vaccine Fast-Dissolving Dosage Form Using Starch
  • Streptococcus Vaccine Compositions And Methods Of Using The Same
  • Treating Naturally Occurring Age-Related Decline In Human Immune Function Or Acquired Or Transient State Of Immune Compromise By Administering Antigen And Dehydroepiandrosterone Sulfate
  • Administering To The Patient An Immunologically Effective Amount Of A Helicobacter Urease Or Urease Subunits As Antigen
  • Vault Compositions For Immunization
  • Vault Compositions For Immunization Against Chlamydia Genital Infection
  • Vault Compositions For Immunization
  • Forming Antibodies
  • For Mucosal Administration, Preferably Intranasally, Of Pneumococcal Surface Protein A (Pspa) Or Immunogenic Fragment Thereof To Elicit Immunological Response And Protection Against Pneumococcal Colonization, Systemic Infections
  • Vaccine Compositions And Method For Enhancing An Immune Response
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf00915547

    DOI

    http://dx.doi.org/10.1007/bf00915547

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1014883972

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/3301884


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antigens", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immune System", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunization", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin A, Secretory", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mucous Membrane", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Molecular Engineering Associates, Inc., Birmingham, Alabama", 
              "id": "http://www.grid.ac/institutes/grid.454428.b", 
              "name": [
                "Departments of Microbiology and Medicine, University of Alabama at Birmingham Medical Center, University Station, 35294, Birmingham, Alabama", 
                "Molecular Engineering Associates, Inc., Birmingham, Alabama"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mestecky", 
            "givenName": "Jiri", 
            "id": "sg:person.01213632267.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213632267.99"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/978-94-011-6609-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002247244", 
              "https://doi.org/10.1007/978-94-011-6609-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/221679a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021204902", 
              "https://doi.org/10.1038/221679a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4684-3369-2_67", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021934126", 
              "https://doi.org/10.1007/978-1-4684-3369-2_67"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/257797a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051492156", 
              "https://doi.org/10.1038/257797a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4684-3369-2_40", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039111998", 
              "https://doi.org/10.1007/978-1-4684-3369-2_40"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4684-3369-2_22", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017207838", 
              "https://doi.org/10.1007/978-1-4684-3369-2_22"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1987-07", 
        "datePublishedReg": "1987-07-01", 
        "description": "The selective induction of antibodies in external secretions is desirable for the prevention of various systemic as well as predominantly mucosa-restricted infections. An enormous surface area of mucosal membranes is protected primarily by antibodies that belong, in many species, to the IgA isotype. Such antibodies are produced locally by large numbers of IgA-containing plasma cells distributed in subepithelial spaces of mucosal membranes and in the stroma of secretory glands. In humans and in some animal species, plasma-derived IgA antibodies do not enter external secretions in significant quantities and systemically administered preformed IgA antibodies would be of little use for passive immunization. Systemic administration of microbial antigens may boost an effective S-IgA immune response only in a situation whereby an immunized individual had previously encountered the same antigen by the mucosal route. Local injection of antigen in the vicinity of secretory glands is usually accompanied by an undesirable concomitant systemic response and frequently requires the addition of adjuvants that are unacceptable for administration in humans. Immunization routes that involve ingestion or possibly inhalation of antigens lead to the induction of not only local but also generalized immune responses manifested by the parallel appearance of S-Iga antibodies to ingested or inhaled antigens in secretions of glands distant from the site of immunization. Based on extensive studies in animal models as well as in humans, convincing evidence is available that antigen-sensitized and IgA-committed precursors of plasma cells from GALT are disseminated to the gut, other mucosa-associated tissues, and exocrine glands. However, due to the limited absorption of desired antigens from the gut lumen of orally immunized individuals, repeated large doses of antigens are required for an effective S-IgA response. Novel antigen delivery systems for the stimulation of such responses are currently being examined in several laboratories. Live attenuated or genetically manipulated bacteria expressing other microbial antigens have also been used for selective colonization of gut-associated lymphoid tissues. Unique antigen packaging and the use of adjuvants suitable for oral administration hold promise for an efficient antigen delivery to critical tissues in the intestine and deserve extensive exploration. The oral immunization route appears to have many advantages over systemic immunization.(ABSTRACT TRUNCATED AT 400 WORDS)", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf00915547", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2461008", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2434845", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1092207", 
            "issn": [
              "0271-9142", 
              "1573-2592"
            ], 
            "name": "Journal of Clinical Immunology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "7"
          }
        ], 
        "keywords": [
          "immune response", 
          "IgA antibodies", 
          "immunization routes", 
          "microbial antigens", 
          "plasma cells", 
          "external secretions", 
          "common mucosal immune system", 
          "gut-associated lymphoid tissue", 
          "mucosal membranes", 
          "IgA-containing plasma cells", 
          "novel antigen delivery system", 
          "S-IgA antibodies", 
          "oral immunization route", 
          "inhalation of antigen", 
          "site of immunization", 
          "S-IgA responses", 
          "mucosal immune system", 
          "efficient antigen delivery", 
          "antigen delivery system", 
          "use of adjuvants", 
          "secretory glands", 
          "secretion of glands", 
          "systemic immunization", 
          "passive immunization", 
          "mucosal route", 
          "IgA isotype", 
          "lymphoid tissue", 
          "systemic administration", 
          "immunized individuals", 
          "local injection", 
          "antigen delivery", 
          "such antibodies", 
          "same antigen", 
          "addition of adjuvants", 
          "large doses", 
          "animal models", 
          "immune system", 
          "gut lumen", 
          "antigen", 
          "systemic response", 
          "subepithelial space", 
          "immunization", 
          "antibodies", 
          "secretion", 
          "selective induction", 
          "gland", 
          "mucosa", 
          "adjuvant", 
          "critical tissues", 
          "administration", 
          "tissue", 
          "induction", 
          "current strategies", 
          "hold promise", 
          "limited absorption", 
          "parallel appearance", 
          "delivery system", 
          "humans", 
          "such responses", 
          "response", 
          "cells", 
          "IgA", 
          "inhalation", 
          "animal species", 
          "infection", 
          "doses", 
          "individuals", 
          "stroma", 
          "ingestion", 
          "intestine", 
          "prevention", 
          "isotypes", 
          "stimulation", 
          "gut", 
          "injection", 
          "lumen", 
          "systemic", 
          "selective colonization", 
          "GALT", 
          "delivery", 
          "use", 
          "evidence", 
          "enormous surface area", 
          "membrane", 
          "extensive study", 
          "study", 
          "appearance", 
          "colonization", 
          "route", 
          "large number", 
          "little use", 
          "bacteria", 
          "promise", 
          "laboratory", 
          "significant quantities", 
          "addition", 
          "strategies", 
          "sites", 
          "extensive exploration", 
          "number", 
          "area", 
          "system", 
          "exploration", 
          "precursors", 
          "absorption", 
          "situation", 
          "species", 
          "model", 
          "advantages", 
          "surface area", 
          "quantity", 
          "packaging", 
          "space", 
          "vicinity"
        ], 
        "name": "The common mucosal immune system and current strategies for induction of immune responses in external secretions", 
        "pagination": "265-276", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1014883972"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf00915547"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "3301884"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf00915547", 
          "https://app.dimensions.ai/details/publication/pub.1014883972"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:46", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_215.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf00915547"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00915547'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00915547'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00915547'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00915547'


     

    This table displays all metadata directly associated to this object as RDF triples.

    232 TRIPLES      21 PREDICATES      153 URIs      139 LITERALS      14 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf00915547 schema:about N2c76c057ac2947bda9bff39c9bf64245
    2 N2c958afa98ef422d8121c3299c024072
    3 N30f9b404e50548f6ba0d68fb7208d9ca
    4 N3e8330937694422097a4943ceb9e46c5
    5 N6958ac779dbe4617bd8c24660d9ddb66
    6 Nb157ac864690495fa6a4570db1e406eb
    7 Ncf0397d9efa94d98af1f717f19f12ea2
    8 anzsrc-for:11
    9 anzsrc-for:1107
    10 schema:author N5ba230d9a6544c7981aa35bb1a6e3275
    11 schema:citation sg:pub.10.1007/978-1-4684-3369-2_22
    12 sg:pub.10.1007/978-1-4684-3369-2_40
    13 sg:pub.10.1007/978-1-4684-3369-2_67
    14 sg:pub.10.1007/978-94-011-6609-6
    15 sg:pub.10.1038/221679a0
    16 sg:pub.10.1038/257797a0
    17 schema:datePublished 1987-07
    18 schema:datePublishedReg 1987-07-01
    19 schema:description The selective induction of antibodies in external secretions is desirable for the prevention of various systemic as well as predominantly mucosa-restricted infections. An enormous surface area of mucosal membranes is protected primarily by antibodies that belong, in many species, to the IgA isotype. Such antibodies are produced locally by large numbers of IgA-containing plasma cells distributed in subepithelial spaces of mucosal membranes and in the stroma of secretory glands. In humans and in some animal species, plasma-derived IgA antibodies do not enter external secretions in significant quantities and systemically administered preformed IgA antibodies would be of little use for passive immunization. Systemic administration of microbial antigens may boost an effective S-IgA immune response only in a situation whereby an immunized individual had previously encountered the same antigen by the mucosal route. Local injection of antigen in the vicinity of secretory glands is usually accompanied by an undesirable concomitant systemic response and frequently requires the addition of adjuvants that are unacceptable for administration in humans. Immunization routes that involve ingestion or possibly inhalation of antigens lead to the induction of not only local but also generalized immune responses manifested by the parallel appearance of S-Iga antibodies to ingested or inhaled antigens in secretions of glands distant from the site of immunization. Based on extensive studies in animal models as well as in humans, convincing evidence is available that antigen-sensitized and IgA-committed precursors of plasma cells from GALT are disseminated to the gut, other mucosa-associated tissues, and exocrine glands. However, due to the limited absorption of desired antigens from the gut lumen of orally immunized individuals, repeated large doses of antigens are required for an effective S-IgA response. Novel antigen delivery systems for the stimulation of such responses are currently being examined in several laboratories. Live attenuated or genetically manipulated bacteria expressing other microbial antigens have also been used for selective colonization of gut-associated lymphoid tissues. Unique antigen packaging and the use of adjuvants suitable for oral administration hold promise for an efficient antigen delivery to critical tissues in the intestine and deserve extensive exploration. The oral immunization route appears to have many advantages over systemic immunization.(ABSTRACT TRUNCATED AT 400 WORDS)
    20 schema:genre article
    21 schema:isAccessibleForFree false
    22 schema:isPartOf N121d40b30cf948c7bc14ab33f8e05950
    23 N79e2449e17bf42d18c34c154a0f47a45
    24 sg:journal.1092207
    25 schema:keywords GALT
    26 IgA
    27 IgA antibodies
    28 IgA isotype
    29 IgA-containing plasma cells
    30 S-IgA antibodies
    31 S-IgA responses
    32 absorption
    33 addition
    34 addition of adjuvants
    35 adjuvant
    36 administration
    37 advantages
    38 animal models
    39 animal species
    40 antibodies
    41 antigen
    42 antigen delivery
    43 antigen delivery system
    44 appearance
    45 area
    46 bacteria
    47 cells
    48 colonization
    49 common mucosal immune system
    50 critical tissues
    51 current strategies
    52 delivery
    53 delivery system
    54 doses
    55 efficient antigen delivery
    56 enormous surface area
    57 evidence
    58 exploration
    59 extensive exploration
    60 extensive study
    61 external secretions
    62 gland
    63 gut
    64 gut lumen
    65 gut-associated lymphoid tissue
    66 hold promise
    67 humans
    68 immune response
    69 immune system
    70 immunization
    71 immunization routes
    72 immunized individuals
    73 individuals
    74 induction
    75 infection
    76 ingestion
    77 inhalation
    78 inhalation of antigen
    79 injection
    80 intestine
    81 isotypes
    82 laboratory
    83 large doses
    84 large number
    85 limited absorption
    86 little use
    87 local injection
    88 lumen
    89 lymphoid tissue
    90 membrane
    91 microbial antigens
    92 model
    93 mucosa
    94 mucosal immune system
    95 mucosal membranes
    96 mucosal route
    97 novel antigen delivery system
    98 number
    99 oral immunization route
    100 packaging
    101 parallel appearance
    102 passive immunization
    103 plasma cells
    104 precursors
    105 prevention
    106 promise
    107 quantity
    108 response
    109 route
    110 same antigen
    111 secretion
    112 secretion of glands
    113 secretory glands
    114 selective colonization
    115 selective induction
    116 significant quantities
    117 site of immunization
    118 sites
    119 situation
    120 space
    121 species
    122 stimulation
    123 strategies
    124 stroma
    125 study
    126 subepithelial space
    127 such antibodies
    128 such responses
    129 surface area
    130 system
    131 systemic
    132 systemic administration
    133 systemic immunization
    134 systemic response
    135 tissue
    136 use
    137 use of adjuvants
    138 vicinity
    139 schema:name The common mucosal immune system and current strategies for induction of immune responses in external secretions
    140 schema:pagination 265-276
    141 schema:productId N13e94a5c22da4f9983288441b728e1e5
    142 N9983dff408984d10abfdc8697ac283a5
    143 Nbf82998c52aa4346b2fcdcc1178ecc77
    144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014883972
    145 https://doi.org/10.1007/bf00915547
    146 schema:sdDatePublished 2022-11-24T20:46
    147 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    148 schema:sdPublisher Na774a57acace49279e09a741d17848d7
    149 schema:url https://doi.org/10.1007/bf00915547
    150 sgo:license sg:explorer/license/
    151 sgo:sdDataset articles
    152 rdf:type schema:ScholarlyArticle
    153 N121d40b30cf948c7bc14ab33f8e05950 schema:issueNumber 4
    154 rdf:type schema:PublicationIssue
    155 N13e94a5c22da4f9983288441b728e1e5 schema:name dimensions_id
    156 schema:value pub.1014883972
    157 rdf:type schema:PropertyValue
    158 N2c76c057ac2947bda9bff39c9bf64245 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Immunization
    160 rdf:type schema:DefinedTerm
    161 N2c958afa98ef422d8121c3299c024072 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Animals
    163 rdf:type schema:DefinedTerm
    164 N30f9b404e50548f6ba0d68fb7208d9ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Immunoglobulin A, Secretory
    166 rdf:type schema:DefinedTerm
    167 N3e8330937694422097a4943ceb9e46c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Humans
    169 rdf:type schema:DefinedTerm
    170 N5ba230d9a6544c7981aa35bb1a6e3275 rdf:first sg:person.01213632267.99
    171 rdf:rest rdf:nil
    172 N6958ac779dbe4617bd8c24660d9ddb66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Antigens
    174 rdf:type schema:DefinedTerm
    175 N79e2449e17bf42d18c34c154a0f47a45 schema:volumeNumber 7
    176 rdf:type schema:PublicationVolume
    177 N9983dff408984d10abfdc8697ac283a5 schema:name pubmed_id
    178 schema:value 3301884
    179 rdf:type schema:PropertyValue
    180 Na774a57acace49279e09a741d17848d7 schema:name Springer Nature - SN SciGraph project
    181 rdf:type schema:Organization
    182 Nb157ac864690495fa6a4570db1e406eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Mucous Membrane
    184 rdf:type schema:DefinedTerm
    185 Nbf82998c52aa4346b2fcdcc1178ecc77 schema:name doi
    186 schema:value 10.1007/bf00915547
    187 rdf:type schema:PropertyValue
    188 Ncf0397d9efa94d98af1f717f19f12ea2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Immune System
    190 rdf:type schema:DefinedTerm
    191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    192 schema:name Medical and Health Sciences
    193 rdf:type schema:DefinedTerm
    194 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    195 schema:name Immunology
    196 rdf:type schema:DefinedTerm
    197 sg:grant.2434845 http://pending.schema.org/fundedItem sg:pub.10.1007/bf00915547
    198 rdf:type schema:MonetaryGrant
    199 sg:grant.2461008 http://pending.schema.org/fundedItem sg:pub.10.1007/bf00915547
    200 rdf:type schema:MonetaryGrant
    201 sg:journal.1092207 schema:issn 0271-9142
    202 1573-2592
    203 schema:name Journal of Clinical Immunology
    204 schema:publisher Springer Nature
    205 rdf:type schema:Periodical
    206 sg:person.01213632267.99 schema:affiliation grid-institutes:grid.454428.b
    207 schema:familyName Mestecky
    208 schema:givenName Jiri
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213632267.99
    210 rdf:type schema:Person
    211 sg:pub.10.1007/978-1-4684-3369-2_22 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017207838
    212 https://doi.org/10.1007/978-1-4684-3369-2_22
    213 rdf:type schema:CreativeWork
    214 sg:pub.10.1007/978-1-4684-3369-2_40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039111998
    215 https://doi.org/10.1007/978-1-4684-3369-2_40
    216 rdf:type schema:CreativeWork
    217 sg:pub.10.1007/978-1-4684-3369-2_67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021934126
    218 https://doi.org/10.1007/978-1-4684-3369-2_67
    219 rdf:type schema:CreativeWork
    220 sg:pub.10.1007/978-94-011-6609-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002247244
    221 https://doi.org/10.1007/978-94-011-6609-6
    222 rdf:type schema:CreativeWork
    223 sg:pub.10.1038/221679a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021204902
    224 https://doi.org/10.1038/221679a0
    225 rdf:type schema:CreativeWork
    226 sg:pub.10.1038/257797a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051492156
    227 https://doi.org/10.1038/257797a0
    228 rdf:type schema:CreativeWork
    229 grid-institutes:grid.454428.b schema:alternateName Molecular Engineering Associates, Inc., Birmingham, Alabama
    230 schema:name Departments of Microbiology and Medicine, University of Alabama at Birmingham Medical Center, University Station, 35294, Birmingham, Alabama
    231 Molecular Engineering Associates, Inc., Birmingham, Alabama
    232 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...